Showing results (1-10 of 603) with videos related to
Sort By:
Pageof 61
Annals of the New York Academy of Sciences|January 1, 1986
Gene conversion. A mechanism to explain HLA-D region and disease associationC G Fathman, J Goronzy, C WeyandThe Journal of Clinical Investigation|June 1, 1987
Administration in vivo of recombinant interleukin 2 protects mice against septic deathC Weyand, J Goronzy, C G Fathman, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1989
Enhanced cell-mediated protection against fatal Escherichia coli septicemia induced by treatment with recombinant IL-2J Goronzy, C Weyand, J Quan, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1987
Heterogeneity of signal requirements in T cell activation within a panel of human proliferative T cell clonesJ Goronzy, C Weyand, J Imboden, et al.The Journal of Clinical Investigation|March 1, 1986
Shared T cell recognition sites on human histocompatibility leukocyte antigen class II molecules of patients with seropositive rheumatoid arthritisJ Goronzy, C M Weyand, C G FathmanJournal of Immunology (Baltimore, Md. : 1950)|March 1, 1987
Modulation of CD4 by antigenic activationC M Weyand, J Goronzy, C G FathmanProceedings of the National Academy of Sciences of the United States of America|February 1, 1986
Human T-cell clones used to define functional epitopes on HLA class II moleculesC M Weyand, J Goronzy, C G FathmanThe Journal of Experimental Medicine|September 1, 1986
Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4J Goronzy, C M Weyand, C G FathmanTransplantation|June 1, 1989
Immunosuppression by anti-CD4 treatment in vivo. Persistence of secondary antiviral immune responsesC M Weyand, J Goronzy, K Swarztrauber, et al.Transplantation|June 1, 1989
Immunosuppression by anti-CD4 treatment in vivo. Cellular and humoral responses to alloantigensC M Weyand, J Goronzy, K Swarztrauber, et al.Pageof 61